Tests for Scleroderma Renal Crisis
When evaluating suspected scleroderma renal crisis (SRC), immediately obtain blood pressure measurements, serum creatinine, complete blood count with peripheral smear, and urinalysis—these core tests establish the diagnosis and guide urgent management.
Diagnostic Criteria and Essential Laboratory Tests
The diagnosis of SRC requires specific laboratory findings alongside clinical features 1:
Blood Pressure Assessment
- New onset BP >150/85 mmHg OR increase ≥20 mmHg from baseline systolic pressure 1
- Home blood pressure monitoring should be encouraged in all early diffuse cutaneous SSc patients 2
- Note: Approximately 10% of SRC cases are normotensive, making blood pressure alone insufficient for exclusion 3
Renal Function Tests
- Serum creatinine with ≥10% increase from baseline defines the renal decline component 1
- Serial measurements are critical as acute kidney injury can progress rapidly
Hematologic Studies
- Complete blood count with peripheral smear to detect:
- The presence of schistocytes on peripheral smear confirms thrombotic microangiopathy 6
Urinalysis
- Proteinuria
- Hematuria
- Active sediment
- These findings support the diagnosis but are not specific 5
Additional Supportive Laboratory Tests
Serologic Markers
- Anti-RNA polymerase III antibodies—present in one-third of SRC patients and identify high-risk individuals 2, 4
- Anti-centromere antibodies are typically absent in SRC 5
- ANA with speckled pattern is associated with SRC 5
Renin-Angiotensin System
- Plasma renin activity—hyperreninaemia is characteristic of SRC 5
- This test helps confirm the pathophysiologic mechanism but is not required for diagnosis
Role of Renal Biopsy
Renal biopsy is NOT necessary when SRC presents with classical features 4. However, it serves specific purposes:
- Confirms diagnosis in atypical presentations (e.g., normotensive SRC, unclear serologies) 7
- Excludes overlapping conditions that cause acute renal failure in SSc patients 6
- Helps predict prognosis and guide treatment decisions 4, 6
Histologic Findings
When performed, biopsy reveals thrombotic microangiopathy with 6:
- Myxoid intimal changes
- Vascular thrombi
- "Onion skin" lesions
- Fibrointimal sclerosis
- Prominent small vessel involvement
Imaging Studies
While not explicitly detailed in the guidelines for SRC diagnosis, imaging may be needed to:
- Evaluate for pulmonary edema (chest X-ray) in hypertensive crisis
- Assess for pericardial effusion—a risk factor for SRC 2
- Rule out other causes of acute renal failure
Risk Stratification Tests
For patients at high risk (early diffuse cutaneous SSc), screening includes 2:
- Regular blood pressure monitoring—the most critical screening tool
- Anti-RNA polymerase III antibody testing when available
- Assessment for other high-risk features:
Critical Pitfalls to Avoid
- Do not delay treatment waiting for biopsy results in classic presentations—SRC requires immediate ACE inhibitor therapy 4
- Do not exclude SRC based on normal blood pressure alone—normotensive SRC occurs in 10% of cases 3
- Do not overlook the diagnosis in patients with refractory pleural/ascitic effusions preceding acute kidney injury 3
- Recognize that absence of anti-RNA polymerase III antibodies does not exclude SRC—the test is not universally available and only positive in one-third of cases 2, 4
Practical Testing Algorithm
- Immediate bedside: Blood pressure measurement
- Stat laboratory tests: Serum creatinine, CBC with peripheral smear, urinalysis
- Send within 24 hours: Anti-RNA polymerase III antibodies (if not previously tested), plasma renin activity
- Reserve for atypical cases: Renal biopsy when diagnosis is uncertain or overlapping conditions suspected
- Supportive imaging: Chest X-ray if pulmonary edema suspected, echocardiogram if pericardial effusion or cardiac involvement present
The key is rapid recognition through simple laboratory tests rather than waiting for specialized studies, as early aggressive ACE inhibitor therapy dramatically improves outcomes 5, 4.